Study on Strategies for Non-Heart Beating Liver
肝脏无心跳治疗策略研究
基本信息
- 批准号:11470137
- 负责人:
- 金额:$ 4.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Sinusoidal endothelial cell (SEC) injury is a major abnormality in the liver transplanted from non-heart beating donors. It is important to protect SECs for the establishment of non-heartbcating liver transplantationVEGF is a factor essential for maintenance as well as proliferation of SECs in primary culture. We demonstrated that VEGF also acted as avascular permeability factor through up-regulation of the porosity on SECs. Furthermore, VEGF inhibited contraction of stellate cells, pericytes of SECs, suggesting that VEGF can regulate microcirculation in the hepatic sinusoids. VEGF expression in hepatocytes was increased in rat liver after cold preservation in UW solution, but mRNA expressions of VBGFR-1 and VEGFR-1 were decreased prior to the development of SEC in jury These results may suggest that VEGF cannot work effectively on SECs in the cold preserved liver, and also that exogenous VBGF cannot prevent SEC from injuryKupffer cells were markedly activated in the cold preserved liver, and this activation contributed to SEC injury after orthotopic transplantation of such livers. We found that activated Kupffer cells expressed osteopontin an essential cytokine for initiation of Th1 immune response. Also, we demonstrated that osteopontin played a major role as a chemokine in macrophage migration into the liver using mice with different alleles of osteopontin gene, suggesting that the modulation of osteopontin expression in Kupffer cells may be another strategy for protection of the SECs. We made transgenic mice expressing osteopontin very highly in the liver using human serum amyloid P component promotor as a vector specific for hepatocytes Investigations to prove our hypothesis are now in progress
正弦内皮细胞(SEC)损伤是无心跳供体移植肝脏的主要异常。保护SEC对于非心跳肝移植的建立非常重要。VEGF是原代培养中SEC的维持和增殖所必需的因素。我们证明 VEGF 还可以通过上调 SEC 的孔隙率发挥无血管通透性因子的作用。此外,VEGF抑制星状细胞、SEC周细胞的收缩,表明VEGF可以调节肝窦的微循环。在UW溶液中冷保存后,大鼠肝脏中肝细胞中的VEGF表达增加,但在损伤中SEC发生之前,VBGFR-1和VEGFR-1的mRNA表达降低。这些结果可能表明VEGF不能在大鼠肝脏中有效地作用于SEC。冷保存肝脏中Kupffer细胞明显活化,且外源性VBGF不能防止SEC损伤。Kupffer细胞在冷保存肝脏中显着活化,这种活化导致了此类肝脏原位移植后的SEC损伤。我们发现活化的库普弗细胞表达骨桥蛋白,骨桥蛋白是启动 Th1 免疫反应的重要细胞因子。此外,我们使用具有不同骨桥蛋白基因等位基因的小鼠证明骨桥蛋白作为趋化因子在巨噬细胞迁移到肝脏中发挥着重要作用,这表明调节Kupffer细胞中的骨桥蛋白表达可能是保护SEC的另一种策略。我们使用人血清淀粉样蛋白 P 成分启动子作为肝细胞特异性载体,制作了在肝脏中高度表达骨桥蛋白的转基因小鼠。证明我们假设的研究正在进行中
项目成果
期刊论文数量(96)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Osada N,Mochida S,Inao M,Mashimo Y,Fujiwara K.: "Apoptisis in dissociation between DNA synthesis and cellular functions of activated hepatic stellate cells : A study with carbon tetrachloride-induced rat liver injury."Biochemical Biophysical Research Comm
Osada N、Mochida S、Inao M、Mashimo Y、Fujiwara K.:“活化肝星状细胞 DNA 合成与细胞功能之间的细胞凋亡:四氯化碳诱导的大鼠肝损伤的研究。”生化生物物理研究通讯
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujimori K, Mochida S, Matsui A, Ohno A, Fujiwara K.: "Possible mechanisms of evaluation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients"J Gastroenterol. 7. 40-46 (2002)
Fujimori K、Mochida S、Matsui A、Ohno A、Fujiwara K.:“慢性丙型肝炎患者干扰素-β 治疗期间血清转氨酶水平评估的可能机制”J Gastroenterol。 7. 40-46 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Niimi Y, Mochida S, Matsui A, mao M, FujiwaraK.: "PKC-and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation"Hepatology Res. 21. 261-267 (2001)
Niimi Y、Mochida S、Matsui A、mao M、Fujiwara K.:“VEGF 刺激后人脐静脉内皮细胞中 VEGF 受体表达的 PKC 和 MAPK 独立上调”肝病学研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujiwara K, Mochida S: "Etiology and pathophysiology of fulminant hepatic failure"Molecular Biology and Immunology for the Treatment of Intractable Liver Diseases, Tsuji T, et al.(eds), Elsevier Science, Amsterdam. 275-284 (2002)
Fujiwara K、Mochida S:“暴发性肝衰竭的病因学和病理生理学”治疗顽固性肝病的分子生物学和免疫学,Tsuji T 等人(编),Elsevier Science,阿姆斯特丹。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishikawa K, Mochida S, Mashiba S, et al.: "Expression of Vascular endothelial growth factor in non-parenchymal as well as parenchymal cells in rat liver after necrosis"Biochem Biophys Res Commun. 254. 587-593 (1999)
Ishikawa K、Mochida S、Mashiba S 等人:“坏死后大鼠肝脏非实质细胞和实质细胞中血管内皮生长因子的表达”Biochem Biophys Res Commun。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJIWARA Kenji其他文献
FUJIWARA Kenji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJIWARA Kenji', 18)}}的其他基金
Suppression of Pancreatic cancer neural invasion by regulation of Axon guidance molecule
调控Axon引导分子抑制胰腺癌神经侵袭
- 批准号:
20K22817 - 财政年份:2020
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
NQR Study of Superconducting Mechanism mediated by Valence Fluctuations
价态涨落介导的超导机制的NQR研究
- 批准号:
21540338 - 财政年份:2009
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic Polymorphisms in Promoter Regions of Osteopontin Gene as Host Factors to Determine Th1 Immune Reactions against Hepatitis Virus.
骨桥蛋白基因启动子区的遗传多态性作为宿主因素确定针对肝炎病毒的 Th1 免疫反应。
- 批准号:
14370191 - 财政年份:2002
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New devices in anticoagulant therapy for massive hepatic necrosis through sinusoidal fibrin deposition
通过肝窦纤维蛋白沉积抗凝治疗大面积肝坏死的新装置
- 批准号:
06454258 - 财政年份:1994
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Purification of hepatocyte comitogenic factor in plasma membrane and its action site (s) in hepatocyte proliferation.
质膜中肝细胞有丝分裂因子的纯化及其在肝细胞增殖中的作用位点。
- 批准号:
04454240 - 财政年份:1992
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Factors Associated with Insufficient Liver Regeneration in Fulminant Hepatic Failure
暴发性肝衰竭中肝脏再生不足的相关因素
- 批准号:
01480223 - 财政年份:1989
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
ROLE OF SUPEROXIDE FROM MACROPHAGES IN HEPATIC FIBROSIS
巨噬细胞超氧化物在肝纤维化中的作用
- 批准号:
60480207 - 财政年份:1985
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
OTUD1调控RIPK1去泛素化修饰在内皮细胞炎性损伤介导的放射后脑微循环灌注障碍中的机制研究
- 批准号:82301568
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向分子超声定位显微镜对肝衰竭微循环障碍和炎症可视化及治疗的实验研究
- 批准号:82302222
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于线粒体能量代谢及微循环障碍的多参数MR诊断和预测心脏移植物血管病研究
- 批准号:82371903
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
氧敏感MRI分子成像评价HIF1α-VEGF信号通路诱导糖尿病心肌缺氧损伤及微循环障碍的机制研究
- 批准号:82371925
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
舒心饮激活Dsg2/VEGF促心肌微血管新生治疗冠脉微循环障碍的作用机制研究
- 批准号:82374347
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Cerebral microcirculatory disturbance and astrocyte
脑微循环障碍与星形胶质细胞
- 批准号:
25462233 - 财政年份:2013
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Significance of microcirculatory disturbance of basilar ventricular septum in cases of sudden cardiac death
基底室间隔微循环障碍在心源性猝死中的意义
- 批准号:
16590533 - 财政年份:2004
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Impact of endothelin-1 on microcirculatory disturbance after partial hepatectomy under ischemia/reperfusion in thioacetamide-induced cirrhotic rats
内皮素1对硫代乙酰胺诱导肝硬化大鼠肝部分切除缺血/再灌注后微循环障碍的影响
- 批准号:
13671295 - 财政年份:2001
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Protection of hepatic microcirculatory disturbance due to the ischemia-reperfusion injury
对缺血再灌注损伤引起的肝脏微循环障碍的保护作用
- 批准号:
13671278 - 财政年份:2001
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional Morphology of Coronary Arteriol.es in Relation to Coronary Microcirculatory Disturbance by Micro-imaging Techniques
显微成像技术研究冠状动脉功能形态与冠状动脉微循环障碍的关系
- 批准号:
12670714 - 财政年份:2000
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)